Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
Background Health benefits of postpartum antiretroviral therapy (ART) for human immunodeficiency virus (HIV) positive women with high CD4+ T-counts have not been assessed in randomized trials. Methods Asymptomatic, HIV-positive, non-breastfeeding women with pre-ART CD4+ T-cell counts ≥ 400 cells/mm...
Saved in:
Similar Items
-
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
by: Judith S. Currier, et al.
Published: (2018) -
Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>
by: Currier J., et al.
Published: (2017) -
Pre-cART elevation of CRP and CD4<sup>+</sup>t-cell immune activation associated with HIV clinical progression in a multinational case-cohort study
by: Ashwin Balagopal, et al.
Published: (2018) -
A journalism feature : the art of investment
by: Poh, Renee Mei Yan, et al.
Published: (2015) -
Prolactin directly enhanced Na<sup>+</sup>/K<sup>+</sup>- and Ca<sup>2+</sup>-ATPase activities in the duodenum of female rats
by: Narattaphol Charoenphandhu, et al.
Published: (2018)